|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4745 | |
| A61K 31/497 | |||
| A61P 35/00 | |||
| A61K 9/00 |
| (11) | Number of the document | 3389660 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16816563.7 |
| Date of filing the European patent application | 2016-12-08 | |
| (97) | Date of publication of the European application | 2018-10-24 |
| (45) | Date of publication and mention of the grant of the patent | 2019-10-16 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/065503 |
| Date | 2016-12-08 |
| (87) | Number | WO 2017/105982 |
| Date | 2017-06-22 |
| (30) | Number | Date | Country code |
| 201562267462 P | 2015-12-15 | US |
| (72) |
BECKMANN, Richard Paul, US
DONOHO, Gregory Paul, US
LIN, Aimee Karis, US
WACHECK, Volker, US
|
| (73) |
Eli Lilly and Company,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (54) | COMBINATION THERAPY FOR CANCER |
| COMBINATION THERAPY FOR CANCER |